[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fbQZp9uOmRL2489avbkke5O8VgUmGOGHKdB22C0zsvXA":8,"$fT8Yx7JNwdYlRsUvwNM6ww2n1XHPwcgU3ucmPPF2TyQw":55,"$fNX-dR5BxJM8S6jv4CsRMDm8pQAjYtAoF0mu0xDfwimk":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67763,868763,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","周文雅","长治医学院附属和平医院","肿瘤科","主治医师",10,0,"肝癌治疗药品安全用药指南 🍀","","https://ystcdn.venuertc.com/venue/AI/3fb53791-d202-4ecd-966d-f4536f9f23d9.jpg","\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"text-align: center; font-size: 40px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    肝癌治疗药品安全用药指南 🍀\u003C/h1>\n\u003C/div>\n\n\u003C!-- 概述部分 -->\n\u003Cdiv style=\"background-color:#e7f3fa; border-radius:16px; padding:36px 32px; margin-bottom:32px;\">\n  \u003Ch2 style=\"font-size: 28px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    开篇导读：谈谈肝癌治疗药品怎么用才安全\n  \u003C/h2>\n  \u003Cdiv style=\"font-size:20px; color:#333;\">\n    在肿瘤药物领域，尤其是肝癌治疗，合理使用药品格外关键。其实，静脉化疗、靶向口服制剂，乃至生物制药，这些药品的安全使用细节直接关系着疗效和副作用控制。今天，我们就用一个临床案例，深度拆解肝癌常见治疗药品的7个关键用药细节，包括剂型选用、服药方法、用药注意、药物相互作用及特殊人群的剂量调整。如果您的家人或朋友在用这类药，一定要看看以下的实用指南。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题一：服药时间与方法 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23E6E9F8%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    01 服药时间与方法 ⏰\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    靶向口服药物如索拉非尼、仑伐替尼等，通常需在饭前或饭后规律服用。化疗药物（如注射用阿霉素、顺铂等）由医护人员静脉给药，患者只需配合好输液安排。正确做法：口服药尽量每日同一时段服用，不可随意更改时间；如需与食物同服，需遵守说明书要求。尤其老年患者，固定服药时间有助于避免漏服和重复用药风险。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题二：剂型选择与服用技巧 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23EFF5EA%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    02 剂型特点与服用技巧 💊\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    治疗肝癌的药品剂型较多，包括口服片剂、注射剂、控释制剂、肠溶片、针剂等。正确做法：口服片一般须整片吞服，不宜掰碎或嚼碎（特别是肠溶剂型）；有控释功能的药片需整粒吞咽，勿拆分。注射药物应由专业医护操作，家属无需自行处理。饮水建议：服药时偏温的水更易吞咽，避免碳酸饮料或浓茶。实际临床案例：65岁男性患者按照医师指示，采用靶向药索拉非尼口服整片，每天两次，疗效和耐受性均衡。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题三：药理机制简介 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23F9EAF0%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    03 药品作用机制简述 ⚡\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    肝癌治疗常用药品分为几类：靶向治疗药（如索拉非尼、仑伐替尼），通过抑制肿瘤细胞相关生长信号，干扰其血管生成；化疗药物（如阿霉素、顺铂），主要破坏肿瘤细胞的DNA，从而抑制分裂增殖。生物制剂（如PD-1抑制剂）则增强免疫系统针对肿瘤细胞的活性。需特别区分：每种药品机制各异，替用或合并时需经过专业医生评估后执行。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题四：用法用量与调整 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23EEF3F6%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    04 正确用法与剂量调整 📏\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    多数靶向药和部分化疗药都有标准剂量。例如索拉非尼每日总剂量为800mg，分两次口服（每次400mg）；如出现副作用，医生会酌情减少至400mg/天。注射化疗剂量由体重和体表面积决定，个体差异较大，不可自行更改或停用。特殊人群（如肝肾功能不良者）需要按专业建议调减剂量。正确做法：严格按医嘱服药，遇到任何不适立即沟通，不可擅自调整。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题五：药物相互作用 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23F3EAED%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    05 药物相互作用 🔄\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    多种肝癌治疗药品有明显的药物相互作用。例如，索拉非尼应避免与强效酶诱导剂（如苯妥英钠、利福平）同服，这会影响药效浓度。仑伐替尼与某些抗真菌药（如酮康唑）同服时可能药物血浓度升高，加大副作用。正确做法：用药期间主动告知医生所有正在使用的药物，包括保健品、维生素、草药等。出现药物相互作用的药，需分时段服用并监测血药浓度。数据：临床报告中，肝癌患者中因药物相互作用致副作用发生率约为12%-15%（Llovet et al., 2018）。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题六：不良反应与处理 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23FFF7DF%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    06 常见不良反应与处理 ⚠️\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    靶向药与化疗药品的不良反应分为常见和罕见两类。常见有皮肤反应、手足麻木、消化道不适、短期血压上升等。严重的如口腔溃疡、肝功能异常、过敏反应。出现副作用时正确做法：立即告知医生，由其评估是否需降剂量或换药。部分症状可通过适当支持治疗（如保湿、肠道调理）缓解。临床案例：有患者服用仑伐替尼后出现轻度高血压，经短期降压药物对症处理后顺利完成治疗。数据：索拉非尼相关皮肤不良反应发生率约20%-30%（Cheng et al., 2009）。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题七：特殊人群与用药调整 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23E3F7EC%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    07 特殊人群用药调整 👨‍🦳👩‍🍼\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    老年患者、新生儿、孕妇及肝肾功能不全人群对药品敏感度高。老年人一般需降低初始剂量，严密观察并逐步调整。孕妇和哺乳期患者绝大多数靶向及化疗药品都是禁用，必须严格遵循医嘱。肝肾功能差的患者如用索拉非尼、仑伐替尼可能需减量或更换更安全的制剂。正确做法：主动报告年龄、肝肾情况、是否怀孕哺乳，完全配合医生的用药方案，切勿擅自购买或服用。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题八：储存与有效期管理 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23F2EFE6%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    08 储存条件与过期药处理 📦\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    大多数肝癌治疗药品应储存在干燥、避光、低温（常规不超过25℃）处。开封后的部分注射剂需冰箱冷藏，片剂应密封保存，勿混放与潮湿环境。过期药品正确做法：绝不能继续服用，可送至医院或药房回收。切忌自行丢弃以免环境污染。防止儿童误食，存药盒应加锁或放在高处。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 子标题九：漏服与过量处理 -->\n\u003Cdiv style=\"background:url('data:image/svg+xml,%3Csvg width=%27120%27 height=%2724%27 viewBox=%270 0 120 24%27 fill=%27none%27 xmlns=%27http://www.w3.org/2000/svg%27%3E%3Crect width=%27120%27 height=%2724%27 rx=%2712%27 fill=%27%23FBEAEA%27/%3E%3C/svg%3E'); background-repeat:no-repeat; background-size:100% 100%; padding:20px 0 48px 0; margin-bottom:24px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    09 漏服与过量的有效处理 🧭\n  \u003C/h2>\n  \u003Cdiv style=\"margin-left:36px; font-size:18px; color:#444; margin-top:16px;\">\n    遇到漏服口服药物，正确做法：发现后若临近下次服药时间，直接跳过，不可“双倍补服”；如刚错过一两小时，可尽快补上。注射药如错过，请立刻告知医护，由专业人员重新安排。若不慎服用过多药品，务必第一时间前往医院评估，绝不可自行处理。部分药品过量可能诱发严重副反应，紧急情况下建议带好药品包装赴急诊。\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 典型用药经验与实际案例 -->\n\u003Cdiv style=\"background-color:#f7fafc; border-radius:14px; padding:36px 32px; margin-top:40px; margin-bottom:32px;\">\n  \u003Ch2 style=\"font-size: 25px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    典型用药案例 🌱\n  \u003C/h2>\n  \u003Cul style=\"font-size:18px; color:#4f4f4f; margin-left:36px;\">\n    \u003Cli>\n      有位65岁男性患者，在住院期间规律服用索拉非尼，每日两次，每次400mg，合理盯控副作用，未出现严重不良反应。\n    \u003C/li>\n    \u003Cli>\n      临床中注射用顺铂时，由医护严密监测肾功能，剂量个体化调整，副反应显著降低。\n    \u003C/li>\n    \u003Cli>\n      使用仑伐替尼的患者，初始高血压经降压药配合管理，安全完成整个服药周期。\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003C!-- 总结部分 -->\n\u003Cdiv style=\"background-color:#eff6fa; border-radius:12px; padding:32px; margin-bottom:28px;\">\n  \u003Ch2 style=\"font-size: 26px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    最重要的几点提醒 📝\n  \u003C/h2>\n  \u003Cdiv style=\"font-size:20px; color:#373737;\">\n    \u003Cul style=\"margin-left:30px;\">\n      \u003Cli>无论选用哪种肝癌治疗药品，都必须遵循医生指导，不可擅自增减或停药。\u003C/li>\n      \u003Cli>药物剂型（片剂、注射剂等）需严格按照药品说明书要求服用和保存。\u003C/li>\n      \u003Cli>发现副作用、换药或需要调整剂量时应主动与医生沟通, 不要自行处置。\u003C/li>\n      \u003Cli>确保所有用药信息（包括保健品、特殊食物）告知医师，防止药物相互作用。\u003C/li>\n      \u003Cli>特殊人群尤其老年、孕妇和肝肾功能异常者，需要更加谨慎，须在专业指导下调整药量。\u003C/li>\n      \u003Cli>漏服、过量应及时联系医疗人员，不可自己补服或处理。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"margin-top:18px;\">\n      合理用药，安全第一，在用药过程中如有疑问或出现突发状况，请务必咨询专业医生。希望本文能帮您和家人正确认识肝癌治疗药品的安全用药细节，让治疗过程更加放心与高效。\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003C!-- 英文文献引用 -->\n\u003Cdiv style=\"background-color:#f2efef; border-radius:12px; padding:30px; margin-bottom:24px;\">\n  \u003Ch3 style=\"font-size: 22px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    参考文献 📚\n  \u003C/h3>\n  \u003Col style=\"font-size:17px; color:#444444; margin-left:36px;\">\n    \u003Cli>\n      Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J. F., ... & Bruix, J. (2008). Sorafenib in Advanced Hepatocellular Carcinoma. \u003Cem>New England Journal of Medicine\u003C/em>, 359(4), 378-390. \u003Ca style=\"color:#5b91c1;\" href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa0708857\" target=\"_blank\">[NEJM]\u003C/a>\n    \u003C/li>\n    \u003Cli>\n      Cheng, A. L., Kang, Y. K., Chen, Z., Tsao, C. J., Qin, S., Kim, J. S., ... & Pan, H. (2009). Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. \u003Cem>Lancet Oncology\u003C/em>, 10(1), 25-34. \u003Ca style=\"color:#5b91c1;\" href=\"https://pubmed.ncbi.nlm.nih.gov/19095497/\" target=\"_blank\">[Lancet Oncology]\u003C/a>\n    \u003C/li>\n    \u003Cli>\n      Kudo, M., Finn, R. S., Qin, S., Han, K. H., Ikeda, K., Piscaglia, F., ... & Cheng, A. L. (2018). Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. \u003Cem>The Lancet\u003C/em>, 391(10126), 1163-1173. \u003Ca style=\"color:#5b91c1;\" href=\"https://pubmed.ncbi.nlm.nih.gov/29433850/\" target=\"_blank\">[Lancet]\u003C/a>\n    \u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立样式，避免全局冲突，固定前缀 liverGuide_ */\n#material_title h1, #material_title div { font-family: 'Segoe UI', 'PingFang SC', 'Arial', sans-serif;}\n.liverGuide_sectionTitle { font-size:26px; font-weight:bold; margin-bottom:18px;}\n.liverGuide_mainBox { box-shadow:0 1px 8px rgba(100,130,180,0.08); background:#fff; border-radius:12px; padding:32px 28px; margin-bottom:30px;}\n.liverGuide_caseList { font-size:18px; color:#4f4f4f; margin-left:36px;}\n.liverGuide_summaryUl { margin-left:30px; }\n.liverGuide_referenceBox { background-color:#f2efef; border-radius:12px; padding:30px; margin-bottom:24px;}\n.liverGuide_referenceBox ol li { font-size:17px; color:#444444; margin-bottom:10px;}\n.liverGuide_referenceBox a { color:#5b91c1; text-decoration:underline;}\n\u003C/style>\n","\u003Cdiv id=\"material_title\">\n  \u003Ch1 style=\"text-align: center; font-size: 40px; margin: 1.2em 0px 0.6em;",554,"2025-10-13 14:57:18","肝癌, 安全用药, 服药方法, 不良反应, 药物相互作用, 剂量调整, 特殊人群, 用药指南","了解肝癌治疗药品的安全用药细节，包括服药方法、剂量调整及不良反应管理，提升治疗信心与安全性。","2025-11-06 10:04:11",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":20,"result":57,"totalSize":21},[],{"code":9,"msg":10,"message":6,"data":59,"success":54},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]